VALUE OF PHARMACOGENETIC MARKERS FOR CLINICAL USE OF MORPHINE IN ONCOLOGY ArticleBobrova O.P., Shnayder N.A., Petrova M.M., Zyryanov S.K.Российский журнал боли. 2017. С. 95-103
